Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
about
DJ-1 interacts with RACK1 and protects neurons from oxidative-stress-induced apoptosisThe role of oxidative stress in Parkinson's diseaseNew insights into the role of mitochondria in aging: mitochondrial dynamics and moreOxidative stress, mitochondrial dysfunction, and agingMitochondria, calcium and cell death: a deadly triad in neurodegenerationCell death disguised: The mitochondrial permeability transition pore as the c-subunit of the F(1)F(O) ATP synthaseMitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's DiseasesThe regulation and deregulation of Wnt signaling by PARK genes in health and diseaseMetabolomics of human brain aging and age-related neurodegenerative diseasesGenetics of Parkinson's disease - a clinical perspectiveEvaluation of traditional medicines for neurodegenerative diseases using Drosophila modelsRole of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute NeuropathologiesGDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson diseaseMutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humansThe Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypesMitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseasesPINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagyThe Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in DrosophilaAxon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicityQuantitative proteomic analysis of Parkin substrates in Drosophila neurons.Role of X11 and ubiquilin as in vivo regulators of the amyloid precursor protein in DrosophilaCellular stress responses: cell survival and cell deathActivation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's diseaseMitochondrial DNA variants in the pathogenesis of type 2 diabetes - relevance of asian population studies.An integrated micro- and macroarchitectural analysis of the Drosophila brain by computer-assisted serial section electron microscopy.Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling.Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1.Identification and characterization of a novel endogenous murine parkin mutation.Drosophila melanogaster in the study of human neurodegeneration.Engineered disulfide bonds restore chaperone-like function of DJ-1 mutants linked to familial Parkinson's disease.Recent advances in the genetics of Parkinson's disease.Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study.Unravelling the role of defective genes.Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.The C8ORF38 homologue Sicily is a cytosolic chaperone for a mitochondrial complex I subunit.DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy.A meta-analysis of the relationship of the Parkin p.Val380Leu polymorphism to Parkinson's disease.Genetic neuropathology of Parkinson's disease.Molecular insights into Parkinson's disease.
P2860
Q24299536-28E4E38B-3297-441F-9D42-3DA5C496C01AQ24307946-32BD69E4-D799-46B9-A930-D8613249DE34Q24600600-3BE2625B-6136-4AAF-9AFA-233176000155Q24635310-D1BF74D0-1A66-4D4F-B817-006BE2E5B830Q24646020-1DE377DB-2420-42D4-B8D8-D2BA74BBAC08Q26823103-47C423CB-61A5-4D86-B95D-7F1D65ABCBC6Q26859141-429245D7-7085-4ECB-8E83-A23F1A1D9822Q26991986-00BEEC5C-DED4-4856-AA08-7176CABDDF54Q26992344-BD98408D-1D24-406F-BFBE-9D00DA2C59D5Q27022109-D5C6D6C5-A955-4BAB-B9B8-35CAE6054B7AQ27027455-11724FEA-BE66-4B18-AC33-7915EBCBAE54Q28072353-B33F0686-06FB-4838-B7E9-4A07584F7863Q28083626-2B5C6623-1C7A-4D72-98AA-9197E6756213Q28481587-796149CA-17B4-4CE5-B328-28A7A4C7B30CQ28587095-7F57382D-9571-4FAA-8925-8EC624B0BC32Q29615646-B00D8CF8-52B4-4D9B-8AF6-5150ADC84E73Q29616005-A64EE1A1-B9EA-437F-92AD-0139F3799672Q29617091-90E9BA17-D227-4599-ABBC-F71E2DBE4B6EQ30577415-561F8E9A-B014-4A46-BFFB-41D95B80E814Q30844860-3B030637-4C19-4A83-8C0B-802097A72281Q33346273-E083F305-F8C1-4A79-ADAA-AC3D57FCE3B3Q33674213-A7354386-33B5-41A6-A7A0-A1276766F05DQ33690517-48119179-0EF3-4325-AE86-450C9DC8B203Q33718097-1D42E909-DEFF-4836-ADA8-1586500611AEQ33722050-9B6F182C-5F87-48B3-9639-14653ECC4CC2Q33750236-8739C08B-A2A4-487D-BD99-24D5BE7439ADQ33840243-19983B82-7B10-475A-A1F1-06D686598274Q33936625-379BE84B-8227-4B39-9778-33636EDDFDE9Q34012526-36738E51-DF9A-4416-9CA9-2E0EFD5F907BQ34022667-F3FE78F0-3755-4DFB-89DB-75AC30A6AACFQ34078603-F6E60EB9-37A0-4601-A7F9-9B776FF0268CQ34189660-8B671E98-1602-48D6-9A52-AFAFBA9CF77CQ34198178-A610B112-20E2-4970-9049-4280F08CF156Q34201811-0ACB94AD-B2E2-4D9E-B222-74674A0892BBQ34287719-24702CF3-49E9-4C59-97B0-57553A14C42FQ34333891-64FB3347-BC80-4D0C-A5AA-E590E6E3A4E7Q34399382-C1A0FD05-9FA2-439B-9A70-3511B16DCF81Q34597756-A32CEF2B-1148-49F5-A716-80B2F953698AQ34825312-05B0401E-44DB-43A3-9990-716832639D93Q34988753-A56286EA-3601-4A51-8C2C-166EC6F5C0F8
P2860
Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
@en
type
label
Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
@en
prefLabel
Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
@en
P1476
Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
@en
P2093
Mark W Dodson
P304
P356
10.1016/J.CONB.2007.04.010
P577
2007-05-11T00:00:00Z